Clinical Trial Update: Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of super-boosted lopinavir/ritonavir with rifampin was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Tuberculosis

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: University of Miami | Conditions: AIDS, Tuberculosis | Phase 4 | Status: TERMINATED